foxo4-dri senolytic mice baar 2017

foxo4-dri senolytic mice baar 2017 Development of a novel by precise disruption of FOXO4-p53 complex FOXO4-DRI alleviates age-related testosterone secretion

Name: foxo4-dri senolytic mice baar 2017 Development of a novel by precise disruption of FOXO4-p53 complex FOXO4-DRI alleviates age-related testosterone secretion
Brand: equiscorp.hu
SKU: 39381089563
Price: 25.71 USD
Availability: InStock
Rating: 4.1989 (16 reviews)

FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity 2022 Lupus Highlight Therapeutic Targeting of Senescent Cells in Lupus, Lupus Research Program, Congressionally Directed Medical Research Programs The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications

SKU: 39381089563 · From equiscorp.hu

4.2

USD25.71 USD68.71

Pay in 4 interest-free payments of $6.43 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Dehestani, N

User 16 reported being pain-free at week 5, moving from a bedridden state caused by L5 stenosis to full recovery

Migraine would last hours after leaving the light source, which would impact all other activities." "Light bothers me almost every minute of each day

According to Khavinson's bioregulator concept, short peptides like EpitalON are thought to interact with regulatory regions of DNA in specific tissues